Bicocca Open Archive

Logo unimib boa
STRAZZABOSCO, MARIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 22.158
EU - Europa 8.492
AS - Asia 3.650
SA - Sud America 34
Continente sconosciuto - Info sul continente non disponibili 32
OC - Oceania 17
AF - Africa 14
Totale 34.397
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 21.786
CN - Cina 1.503
SE - Svezia 1.467
IE - Irlanda 1.240
IT - Italia 1.207
DE - Germania 1.142
SG - Singapore 1.136
UA - Ucraina 1.099
RU - Federazione Russa 1.002
GB - Regno Unito 520
HK - Hong Kong 498
CA - Canada 369
FI - Finlandia 280
VN - Vietnam 139
FR - Francia 138
IN - India 128
DK - Danimarca 102
TR - Turchia 88
AT - Austria 80
NL - Olanda 67
BE - Belgio 45
JP - Giappone 35
EU - Europa 27
KR - Corea 26
BG - Bulgaria 23
IR - Iran 22
TW - Taiwan 19
BR - Brasile 17
ES - Italia 16
CZ - Repubblica Ceca 14
ID - Indonesia 11
RO - Romania 10
AU - Australia 9
CH - Svizzera 9
PK - Pakistan 9
NZ - Nuova Zelanda 8
PH - Filippine 8
NO - Norvegia 7
PL - Polonia 7
CL - Cile 6
A2 - ???statistics.table.value.countryCode.A2??? 4
CO - Colombia 4
MD - Moldavia 4
MM - Myanmar 4
MY - Malesia 4
SC - Seychelles 4
AR - Argentina 3
EC - Ecuador 3
GR - Grecia 3
MX - Messico 3
PT - Portogallo 3
TH - Thailandia 3
BD - Bangladesh 2
EG - Egitto 2
LK - Sri Lanka 2
LT - Lituania 2
MA - Marocco 2
MU - Mauritius 2
OM - Oman 2
TN - Tunisia 2
UZ - Uzbekistan 2
A1 - Anonimo 1
AE - Emirati Arabi Uniti 1
AM - Armenia 1
AZ - Azerbaigian 1
BO - Bolivia 1
BY - Bielorussia 1
DZ - Algeria 1
GE - Georgia 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
IQ - Iraq 1
JO - Giordania 1
LB - Libano 1
LI - Liechtenstein 1
ME - Montenegro 1
SA - Arabia Saudita 1
UG - Uganda 1
Totale 34.397
Salva come PNG Salva come JPEG
Città #
Ann Arbor 3.259
Woodbridge 2.788
Fairfield 2.114
Houston 1.895
Chandler 1.334
Jacksonville 1.212
Dublin 1.204
Ashburn 1.143
Wilmington 992
Singapore 923
Seattle 868
Frankfurt am Main 799
Cambridge 769
Dearborn 556
New York 552
Princeton 534
Hong Kong 480
Milan 363
Santa Clara 311
Nanjing 288
Lawrence 228
Altamura 204
Lachine 197
Shanghai 171
Beijing 162
San Diego 128
Boardman 108
Shenyang 82
Guangzhou 81
Andover 76
Vienna 74
Nanchang 72
Toronto 69
Hebei 63
Ottawa 62
Helsinki 61
Falls Church 57
Changsha 53
Hangzhou 52
Jiaxing 50
Tianjin 50
Norwalk 48
Dong Ket 47
Mountain View 45
Fremont 43
London 42
Philadelphia 41
Brussels 36
Huizen 36
Jinan 36
Kunming 34
Los Angeles 31
Lissone 29
Redmond 29
Zhengzhou 29
Chicago 27
Rome 27
Pune 26
San Mateo 26
Ningbo 22
Auburn Hills 21
Plovdiv 20
Leawood 19
Taizhou 18
Boston 16
Tappahannock 16
Washington 16
Edmonton 15
Hefei 15
Nürnberg 15
Munich 14
Padova 14
Bologna 13
Fuzhou 13
Montréal 13
Bonndorf 12
Detroit 12
Kilburn 12
Dallas 11
Jakarta 11
Kiev 11
University Park 11
Hounslow 10
New Haven 10
Tokyo 9
Auckland 8
Brno 8
Lanzhou 8
Old Lyme 8
Mumbai 7
Pisa 7
Shenzhen 7
Wuhan 7
Yongsan-gu 7
Bari 6
Busto Arsizio 6
Casalserugo 6
Central 6
Groningen 6
Lappeenranta 6
Totale 25.588
Salva come PNG Salva come JPEG
Nome #
Platelet-derived growth factor-D enables liver myofibroblasts to promote tumor lymphangiogenesis in cholangiocarcinoma 470
Impact of multidisciplinary team approach to liver tumors: 5-Years experience 372
Impact of multidisciplinary team approach to liver tumors in a tertiary center: 5-years experience 343
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 292
Diagnostic Value of Quantitative Perfusion Computed Tomography Technique in the Assessment of Tumor Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma 248
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 234
Trattamento con Sofosbuvir e Ribavirina nei pazienti hcv-positivi listati per il trapianto di fegato: un analisi di costo-efficacia 223
Resveratrol impairs glioma stem cells proliferation and motility by modulating the wnt signaling pathway 215
Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study 209
Long term outcome of acute pancreatitis in Italy: Results of a multicentre study 205
Pathophysiologic implications of innate immunity and autoinflammation in the biliary epithelium 200
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice 197
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 194
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 194
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 191
HCC persistence or recurrence after bridging therapy helps predict transplant list dropout and generate a more equitable exception policy 190
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 189
Pathway-based analysis of primary biliary cirrhosis genome-wide association studies 188
The optimal timing of hepatitis C therapy in liver transplant-eligible patients: Cost-effectiveness analysis of new opportunities 188
Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions 186
Notch signaling regulates tubular morphogenesis during repair from biliary damage in mice 184
Health Related Quality of Life in the Major Liver Conditions 184
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 183
International genome-wide meta-analysis identifies new primary biliary cirrhosis risk loci and targetable pathogenic pathways 182
Classical HLA-DRB1 and DPB1 alleles account for HLA associations with primary biliary cirrhosis 181
Tumor reactive stroma in cholangiocarcinoma: The fuel behind cancer aggressiveness 181
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 180
Epithelial expression of angiogenic growth factors modulate arterial vasculogenesis in human liver development 178
Effect of Silibinin on biliary lipid composition. Experimental and clinical study 176
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 176
The cystic fibrosis transmembrane conductance regulator controls biliary epithelial inflammation and permeability by regulating Src tyrosine kinase activity 176
Health related quality of life in chronic liver diseases 176
Foxa1 and Foxa2 regulate bile duct development in mice 175
Low-dose paclitaxel reduces S100A4 nuclear import to inhibit invasion and hematogenous metastasis of cholangiocarcinoma 175
The impact of liver disease on the health-related quality of life 175
Cholangiocyte biology as relevant to cystic liver diseases 174
Should new antiviral treatments be considered in elderly Chronic Hepatitis C patients? 173
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 172
pka-dependent p-ser- 675 β-catenin phosphorylation increases cholangiocyte motility in pkhd1del4/del4 mice, a model of fibropolycystic liver diseases caused by defective fibrocystin function 172
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 171
Ursodeoxycholic acid stimulates cholangiocyte fluid secretion in mice via CFTR-dependent ATP secretion. 170
Should Sofosbuvir-Based All-Oral Treatment Be Considered In Elderly Chronic Hepatitis C Patients? 170
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 168
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 168
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 168
The challenges of primary biliary cholangitis: What is new and what needs to be done 168
Immunochip analyses identify a novel risk locus for primary biliary cirrhosis at 13q14, multiple independent associations at four established risk loci and epistasis between 1p31 and 7q32 risk variants. 167
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 167
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 166
Morphological and functional features of hepatic cyst epithelium in autosomal dominant polycystic kidney disease. 163
Epithelial-to-Mesenchymal Transition and Cancer Invasiveness: What Can We Learn from Cholangiocarcinoma? 163
Β-Catenin-Mediated Cxcl1 and Cxcl10 Secretion by Fibrocystin-Defective Cholangiocytes Regulates Peribiliary Recruitment of Fibrocytes in Congenital Hepatic Fibrosis 162
Cholangiocarcinoma in Italy: A national survey on clinical characteristics, diagnostic modalities and treatment. Results from the "Cholangiocarcinoma" committee of the Italian Association for the Study of Liver disease 161
Intracellular alkalinization stimulates bile flow and vesicular-mediated exocytosis in IPRL 160
Analysis of liver repair mechanisms in Alagille syndrome and biliary atresia reveals a role for notch signaling 159
ERK1/2-dependent vascular endothelial growth factor signaling sustains cyst growth in polycystin-2 defective mice 159
Vascular biology of the biliary epithelium 159
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 158
Revisiting Epithelial-to-Mesenchymal Transition in Liver Fibrosis: Clues for a Better Understanding of the "reactive" Biliary Epithelial Phenotype 158
Loss of CFTR affects biliary epithelium innate immunity and causes TLR4-NF-κB-mediated inflammatory response in mice 157
Liver transplant in cystic fibrosis: a poll among European centers. A study from the European Liver Transplant Registry 156
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 155
The cholangiopathies: disorders of biliary epithelia 154
Side chain structure determines unique physiologic and therapeutic properties of norursodeoxycholic acid in Mdr2-/- mice 154
Liver Match, a prospective observational cohort study on liver transplantation in Italy: study design and current practice of donor-recipient matching 154
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 154
Novel association of HLA-haplotypes with primary sclerosing cholangitis (PSC) in a southern European population 153
Regulation of activity and apical targeting of the Cl-/HCO3- exchanger in rat hepatocytes. 153
Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib 153
Functional anatomy of normal bile ducts 152
Effect of age on single- and multiple-dose pharmacokinetics of erythromycin 152
Notch signaling and new therapeutic options in liver disease 152
Liver-allocation policies for patients affected by HCC in Europe 152
Characterization and isolation of ductular cells coexpressing neural cell adhesion molecule and Bcl-2 from primary cholangiopathies and ductal plate malformations 151
Genome-wide meta-analyses identify three loci associated with primary biliary cirrhosis 151
"The city of Hepar": Rituals, gastronomy, and politics at the origins of the modern names for the liver 151
The Cost-Effectiveness Of Sofosbuvir And Ribavirin Treatment In Hcv-Infected Patients Listed For Liver Transplantation 151
Monocyte/macrophage peribiliary recruitment by pkhd1-defective cholangiocytes induces expression of avb6 integrin on biliary cysts via tgf-β1 and tnf-α in congenital hepatic fibrosis 150
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 150
Personalized molecular targeted therapy for hepatocellular carcinoma in the era of genome sequencing 150
Effective but costly: How to tackle difficult trade-offs in evaluating health improving technologies in liver diseases 150
Intracellular pH regulation in isolated rat bile duct epithelial cells 149
Purinergic regulation of acid/base transport in human and rat biliary epithelial cell lines. 149
Emerging concepts in biliary repair and fibrosis 149
An international genome-wide meta-analysis of primary biliary cholangitis: Novel risk loci and candidate drugs 149
Isolated idiopathic bile ductular hyperplasia in patients with persistently abnormal liver function tests 148
Sorafenib paradoxically activates the raf/mek/erk signaling in mice with polycystic liver disease (pld) caused by conditional deletion of polycystin-2 148
Cerebral aspergillosis in a liver transplant recipient: a case report of long-term survival after combined treatment with liposomal amphotericin B and surgery 147
Effect of ursodeoxycholic acid on intracellular pH in a bile duct epithelium-like cell line 147
Effect of UDCA on intracellular and biliary pH in isolated rat hepatocyte couplets and perfused livers 147
Effects of angiogenic factor overexpression by human and rodent cholangiocytes in polycystic liver diseases 147
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 147
Valproic Acid Inhibits Proliferation and Reduces Invasiveness in Glioma Stem Cells Through Wnt/β Catenin Signalling Activation 147
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 147
Prediction of progression-free survival in patients presenting with hepatocellular carcinoma within the Milan criteria 146
Effect of Silybin on biliary lipid composition in rats 145
Altered store operated calcium entry increases cAMP production and ERK1/2 phosphorylation in Polycystin-2 defective cholangiocytes 145
Molecular mechanisms driving cholangiocarcinoma invasiveness: an overview 145
Epidemiology of unconjugated hyperbilirubinemia: revisited 143
Cl(-)-HCO3- exchanger in isolated rat hepatocytes: role in regulation of intracellular pH 143
Totale 17.529
Salva come PNG Salva come JPEG
Categoria #
all - tutte 119.286
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 119.286
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20203.963 0 0 0 0 592 686 814 435 627 288 400 121
2020/20214.303 369 357 442 453 331 269 378 313 380 434 274 303
2021/20222.877 130 293 499 219 101 210 133 197 143 199 244 509
2022/20235.338 594 1.602 470 404 435 810 72 278 369 31 178 95
2023/20243.783 151 142 112 179 505 1.038 764 139 333 33 24 363
2024/20253.041 551 1.073 423 324 670 0 0 0 0 0 0 0
Totale 35.399